Andrea A Chan, MD
Urology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 19 years
- Pennsylvania State University College of Medicine, 2007
Offices
4 locations · Community Health Partners · 497 clinicians in this group
Looking this up.
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chan’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A120129 · Current
Licensed to practise in California · since 2012 · expires 2028-01-31 · Pennsylvania State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$110,852
Medicare paid this office $110,852 for 277 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of bladder and urethra using an endoscope | 76 | $15,644 | $191 |
| Return visit (30+ min) | 99 | $14,967 | $96 |
| Short return visit (20+ min) | 79 | $6,451 | $66 |
| New patient visit (45+ min) | 46 | $5,517 | $120 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $5,287 | $311 |
See all 15 services
| Diagnostic exam of bladder and urethra using an endoscope | 76 | $15,644 | $191 |
| Return visit (30+ min) | 99 | $14,967 | $96 |
| Short return visit (20+ min) | 79 | $6,451 | $66 |
| New patient visit (45+ min) | 46 | $5,517 | $120 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $5,287 | $311 |
| New patient visit (30+ min) | 58 | $4,513 | $78 |
| Simple measurement of pressure of urine flow in bladder | 17 | $2,907 | $171 |
| Long return visit (40+ min) | 17 | $2,576 | $136 |
| Simple insertion of temporary bladder tube | 16 | $1,814 | $47 |
| Ultrasound measurement of bladder capacity after voiding | 124 | $1,635 | $9 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,201 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,129 | $59 |
| Urinalysis, manual test | 172 | $976 | $3 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 14 | $400 | $29 |
| Electronic assessment of bladder emptying | 14 | $88 | $6 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 607 | 539 | 504 | 430 | 143 | 187 |
| Diagnostic exam of bladder and urethra using an endoscope | 174 | 146 | 144 | 82 | 38 | 82 |
| Insertion of lower leg neurostimulator electrode | 198 | 77 | 78 | 27 | – | – |
| Simple bladder irrigation and/or instillation | 132 | 119 | 80 | 24 | – | – |
| Simple insertion of temporary bladder tube | 64 | 54 | 70 | 83 | 31 | 39 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 49 | 67 | 41 | – | 22 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
277 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 8% · Women 39% · Also on Medicaid 61% · Health risk score 1.94. Sicker patients than 9 in 10 peers; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 47% · Chronic kidney disease 41% · Coronary heart disease 40% · Heart failure 29% · Depression 28% · Atrial fibrillation 23% · Cancer 20% · COPD 18% · Dementia 15% · Stroke 13%.
The office billed $440,689, Medicare allowed $146,340 and paid $110,852; for 1,655 services of 76 kinds; $2,466 of it was for drugs given in the office and $108,387 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 277 | 1,655 | 71 | 1.94 | $440,689 | $110,852 |
| 2023 | 245 | 888 | 71 | 1.88 | $285,506 | $76,241 |
| 2022 | 851 | 3,806 | 76 | 1.32 | $457,848 | $155,588 |
| 2021 | 819 | 5,408 | 76 | 1.25 | $826,884 | $282,535 |
| 2020 | 754 | 5,827 | 76 | 1.30 | $920,107 | $292,855 |
| 2019 | 766 | 5,565 | 76 | 1.35 | $1,161,100 | $339,903 |
| 2018 | 776 | 4,444 | 76 | 1.30 | $946,305 | $293,760 |
| 2017 | 730 | 4,680 | 76 | 1.28 | $1,112,137 | $334,535 |
| 2016 | 743 | 4,492 | 76 | 1.24 | $873,998 | $279,646 |
| 2015 | 576 | 3,047 | 76 | 1.28 | $563,393 | $199,383 |
| 2014 | 347 | 2,207 | 72 | 1.17 | $230,008 | $133,742 |
| 2013 | 334 | 2,360 | 72 | 1.25 | $250,944 | $158,838 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| New patient visit (45+ min) | 63 | $8,125 | $129 |
| Return visit (30+ min) | 64 | $8,092 | $97 |
| Diagnostic exam of bladder and urethra using an endoscope | 33 | $7,288 | $192 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 21 | $6,180 | $281 |
| New patient visit (30+ min) | 57 | $4,818 | $85 |
| Short return visit (20+ min) | 53 | $4,615 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,340 | $96 |
| Insertion of device into abdomen with pressure and urine flow rate study | 17 | $2,302 | $135 |
| Simple insertion of temporary bladder tube | 22 | $1,580 | $51 |
| Ultrasound measurement of bladder capacity after voiding | 108 | $1,254 | $9 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 22 | $574 | $25 |
| Urinalysis, manual test | 84 | $382 | $3 |
| Electronic assessment of bladder emptying | 23 | $130 | $6 |
2022: 24 services
| Short return visit (20+ min) | 273 | $22,098 | $70 |
| Diagnostic exam of bladder and urethra using an endoscope | 78 | $17,005 | $207 |
| Return visit (30+ min) | 157 | $16,986 | $98 |
| New patient visit (45+ min) | 107 | $12,900 | $121 |
| New patient visit (30+ min) | 122 | $9,775 | $80 |
| Long return visit (40+ min) | 47 | $7,947 | $153 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 16 | $6,930 | None |
| Simple insertion of temporary bladder tube | 51 | $4,357 | $52 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,189 | $105 |
| Ultrasound measurement of bladder capacity after voiding | 374 | $3,690 | $9 |
| Insertion of lower leg neurostimulator electrode | 16 | $2,870 | $106 |
| Short return visit | 59 | $2,738 | $46 |
| New patient visit (60+ min) | 12 | $2,151 | $179 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,822 | $83 |
| Simple bladder irrigation and/or instillation | 22 | $1,449 | $60 |
| Instillation of anti-cancer drug into bladder | 11 | $1,328 | $70 |
| Simple change of bladder tube | 13 | $1,306 | $82 |
| Automated urinalysis test | 399 | $1,015 | $2 |
| Insertion of temporary bladder tube | 24 | $986 | $39 |
| New patient visit (15+ min) | 16 | $939 | $59 |
| Bcg live intravesical instillation, 1 mg | 11 | $839 | None |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $739 | $32 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $556 | $24 |
| Electronic assessment of bladder emptying | 11 | $72 | $7 |
2021: 37 services
| Diagnostic exam of bladder and urethra using an endoscope | 119 | $27,069 | $188 |
| Short return visit (20+ min) | 255 | $21,775 | $73 |
| Return visit (30+ min) | 146 | $17,658 | $101 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 41 | $13,383 | $326 |
| New patient visit (45+ min) | 91 | $11,606 | $128 |
| New patient visit (30+ min) | 118 | $10,554 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $10,377 | None |
| Insertion of lower leg neurostimulator electrode | 19 | $8,545 | $110 |
| Botox | 12 | $7,522 | None |
| Crushing of stone of ureter with insertion of stent using an endoscope | 14 | $5,418 | $387 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 12 | $4,962 | $331 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $4,890 | $272 |
| Insertion of device into abdomen with pressure and urine flow rate study | 26 | $4,480 | $172 |
| Ultrasound scan of pelvic region through rectum | 34 | $4,469 | $118 |
| Ultrasound measurement of bladder capacity after voiding | 401 | $4,445 | $9 |
| Biopsy of prostate gland | 19 | $3,927 | $207 |
| Dilation of urethra using an endoscope | 12 | $3,916 | $280 |
| Simple insertion of temporary bladder tube | 49 | $3,637 | $52 |
| Simple bladder irrigation and/or instillation | 44 | $3,265 | $54 |
| Telephone medical discussion with physician, 5-10 minutes | 53 | $2,756 | $46 |
| Short return visit | 48 | $2,280 | $47 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,263 | $113 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $2,223 | $67 |
| Automated urinalysis test | 551 | $2,019 | $2 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $1,791 | $78 |
| Insertion of stent in ureter using an endoscope | 16 | $1,712 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,572 | $60 |
| Instillation of anti-cancer drug into bladder | 11 | $1,372 | $76 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,275 | $33 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 41 | $1,182 | $29 |
| Insertion of temporary bladder tube | 25 | $1,056 | $39 |
| Ultrasonic guidance for needle placement | 20 | $1,030 | $52 |
| Bcg live intravesical instillation, 1 mg | 11 | $809 | None |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $752 | $24 |
| Simple bladder irrigation and/or instillation | 14 | $482 | $24 |
| Electronic assessment of bladder emptying | 21 | $126 | $6 |
| Injection, ceftriaxone sodium, per 250 mg | 22 | $42 | None |
2020: 36 services
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 11 | $30,730 | $904 |
| Diagnostic exam of bladder and urethra using an endoscope | 128 | $23,648 | $162 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 32 | $21,457 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 63 | $21,229 | $317 |
| Return visit (30+ min) | 182 | $20,738 | $87 |
| Short return visit (20+ min) | 262 | $18,913 | $57 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 11 | $13,419 | $1,220 |
| New patient visit (45+ min) | 93 | $12,369 | $133 |
| Insertion of lower leg neurostimulator electrode | 19 | $8,497 | $110 |
| New patient visit (30+ min) | 88 | $7,467 | $85 |
| Insertion of device into abdomen with pressure and urine flow rate study | 37 | $5,432 | $147 |
| Simple bladder irrigation and/or instillation | 68 | $5,181 | $52 |
| Ultrasound measurement of bladder capacity after voiding | 414 | $4,582 | $9 |
| Biopsy of prostate gland | 21 | $4,418 | $210 |
| Ultrasound scan of pelvic region through rectum | 27 | $3,575 | $123 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $3,347 | $257 |
| Dilation of urethra using an endoscope | 12 | $2,961 | $247 |
| Simple insertion of temporary bladder tube | 43 | $2,786 | $52 |
| Instillation of anti-cancer drug into bladder | 12 | $2,228 | $74 |
| Telephone medical discussion with physician, 5-10 minutes | 63 | $2,228 | $33 |
| Automated urinalysis test | 544 | $2,210 | $2 |
| Bcg live intravesical instillation, 1 mg | 12 | $2,079 | None |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,005 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,999 | $111 |
| Insertion of stent in ureter using an endoscope | 17 | $1,769 | $104 |
| Insertion of temporary bladder tube | 31 | $1,573 | $37 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 32 | $1,485 | $27 |
| Short return visit | 34 | $1,270 | $36 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $1,244 | $50 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 38 | $1,131 | $30 |
| Emergency department visit with moderate level of medical decision making | 11 | $1,113 | $101 |
| Ultrasonic guidance for needle placement | 21 | $1,064 | $51 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $971 | $33 |
| Simple bladder irrigation and/or instillation | 15 | $508 | $25 |
| Electronic assessment of bladder emptying | 39 | $277 | $7 |
| Injection, ceftriaxone sodium, per 250 mg | 21 | $43 | None |
2019: 33 services
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 12 | $44,472 | $855 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 29 | $27,239 | None |
| Return visit (30+ min) | 219 | $26,622 | $88 |
| Diagnostic exam of bladder and urethra using an endoscope | 148 | $26,461 | $152 |
| Insertion of lower leg neurostimulator electrode | 32 | $22,004 | $111 |
| Short return visit (20+ min) | 258 | $18,208 | $56 |
| New patient visit (45+ min) | 120 | $14,931 | $124 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 47 | $14,357 | $293 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 12 | $13,422 | $1,118 |
| New patient visit (30+ min) | 97 | $7,484 | $77 |
| Ultrasound measurement of bladder capacity after voiding | 459 | $6,343 | $10 |
| Simple bladder irrigation and/or instillation | 60 | $6,250 | $53 |
| Insertion of device into abdomen with pressure and urine flow rate study | 47 | $5,996 | $122 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $5,466 | $342 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 14 | $5,278 | $278 |
| Dilation of urethra using an endoscope | 17 | $5,058 | $253 |
| Biopsy of prostate gland | 22 | $5,038 | $210 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 20 | $4,292 | $215 |
| Ultrasound scan of pelvic region through rectum | 26 | $3,383 | $113 |
| Simple insertion of temporary bladder tube | 32 | $3,366 | $53 |
| Automated urinalysis test | 591 | $2,792 | $2 |
| Insertion of stent in ureter using an endoscope | 27 | $2,619 | $94 |
| Long return visit (40+ min) | 20 | $2,338 | $111 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,588 | $106 |
| Ultrasonic guidance for needle placement | 25 | $1,371 | $49 |
| Emergency department visit with moderate level of medical decision making | 14 | $1,346 | $96 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $1,323 | $26 |
| Insertion of temporary bladder tube | 30 | $1,306 | $37 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 43 | $1,286 | $29 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $668 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $619 | $33 |
| Simple bladder irrigation and/or instillation | 11 | $345 | $23 |
| Injection, ceftriaxone sodium, per 250 mg | 28 | $56 | None |
2018: 33 services
| Leuprolide acetate (for depot suspension), 7.5 mg | 34 | $28,837 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 162 | $26,116 | $136 |
| Short return visit (20+ min) | 328 | $21,660 | $54 |
| Return visit (30+ min) | 180 | $18,534 | $82 |
| New patient visit (45+ min) | 142 | $18,071 | $127 |
| Insertion of lower leg neurostimulator electrode | 18 | $11,918 | $109 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 18 | $10,886 | $605 |
| Simple bladder irrigation and/or instillation | 81 | $9,229 | $56 |
| Ultrasound measurement of bladder capacity after voiding | 499 | $9,157 | $13 |
| New patient visit (30+ min) | 105 | $8,780 | $84 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 30 | $8,207 | $274 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 23 | $6,736 | $293 |
| Biopsy of prostate gland | 24 | $5,162 | $199 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 25 | $5,143 | $206 |
| Bcg (intravesical) per instillation | 15 | $5,134 | None |
| Insertion of device into abdomen with pressure and urine flow rate study | 53 | $5,086 | $96 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $4,469 | $344 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 12 | $3,833 | $256 |
| Dilation of urethra using an endoscope | 14 | $3,480 | $232 |
| Instillation of anti-cancer drug into bladder | 15 | $3,309 | $69 |
| Automated urinalysis test | 624 | $3,277 | $3 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,445 | $111 |
| Ultrasound scan of pelvic region through rectum | 29 | $2,395 | $75 |
| Simple insertion of temporary bladder tube | 24 | $1,855 | $50 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 53 | $1,551 | $29 |
| Insertion of temporary bladder tube | 32 | $1,550 | $37 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 35 | $1,525 | $26 |
| Short return visit | 40 | $1,505 | $37 |
| Insertion of stent in ureter using an endoscope | 15 | $1,377 | $92 |
| Ultrasonic guidance for needle placement | 26 | $1,354 | $47 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $446 | $32 |
| Electronic assessment of bladder emptying | 15 | $119 | $7 |
| Injection, ceftriaxone sodium, per 250 mg | 24 | $46 | None |
2017: 32 services
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 17 | $53,955 | $818 |
| Diagnostic exam of bladder and urethra using an endoscope | 177 | $27,400 | $129 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 28 | $23,285 | None |
| Return visit (30+ min) | 209 | $21,893 | $78 |
| Short return visit (20+ min) | 318 | $21,427 | $53 |
| New patient visit (45+ min) | 149 | $18,360 | $123 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 17 | $18,003 | $1,059 |
| Insertion of lower leg neurostimulator electrode | 19 | $16,063 | $104 |
| Ultrasound measurement of bladder capacity after voiding | 495 | $10,588 | $15 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 15 | $10,449 | $697 |
| Bcg (intravesical) per instillation | 19 | $9,105 | None |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 31 | $8,512 | $275 |
| New patient visit (30+ min) | 94 | $7,619 | $81 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 28 | $7,182 | $257 |
| Instillation of anti-cancer drug into bladder | 19 | $6,719 | $74 |
| Insertion of device into abdomen with pressure and urine flow rate study | 57 | $5,350 | $94 |
| Simple bladder irrigation and/or instillation | 42 | $5,072 | $58 |
| Dilation of urethra using an endoscope | 20 | $4,828 | $210 |
| Biopsy of prostate gland | 19 | $3,762 | $198 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $3,711 | $195 |
| Simple insertion of temporary bladder tube | 39 | $3,686 | $48 |
| Automated urinalysis test | 588 | $3,673 | $3 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,354 | $107 |
| Long return visit (40+ min) | 18 | $1,962 | $103 |
| Ultrasound scan of pelvic region through rectum | 22 | $1,800 | $78 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 59 | $1,707 | $29 |
| Insertion of temporary bladder tube | 20 | $1,325 | $39 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 28 | $1,318 | $27 |
| Insertion of stent in ureter using an endoscope | 14 | $1,298 | $93 |
| Ultrasonic guidance for needle placement | 21 | $1,110 | $50 |
| Electronic assessment of bladder emptying | 27 | $171 | $6 |
| Injection, ceftriaxone sodium, per 250 mg | 46 | $92 | None |
2016: 28 services
| Diagnostic exam of bladder and urethra using an endoscope | 177 | $33,546 | $159 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 29 | $25,389 | None |
| Return visit (30+ min) | 217 | $23,886 | $80 |
| New patient visit (45+ min) | 187 | $22,305 | $119 |
| Short return visit (20+ min) | 290 | $19,623 | $54 |
| Insertion of lower leg neurostimulator electrode | 34 | $16,721 | $103 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 19 | $12,862 | $677 |
| Ultrasound measurement of bladder capacity after voiding | 566 | $12,778 | $15 |
| New patient visit (30+ min) | 109 | $9,019 | $83 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 35 | $8,734 | $243 |
| Bcg (intravesical) per instillation | 17 | $7,270 | None |
| Instillation of anti-cancer drug into bladder | 17 | $6,481 | $85 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 20 | $5,130 | $256 |
| Insertion of device into abdomen with pressure and urine flow rate study | 54 | $4,825 | $88 |
| Biopsy of prostate gland | 22 | $4,383 | $175 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 54 | $4,090 | $74 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $3,714 | $195 |
| Automated urinalysis test | 603 | $3,670 | $3 |
| Simple bladder irrigation and/or instillation | 45 | $3,480 | $62 |
| Long return visit (40+ min) | 28 | $3,123 | $101 |
| Simple insertion of temporary bladder tube | 32 | $2,153 | $53 |
| Ultrasound scan of pelvic region through rectum | 24 | $2,101 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,062 | $109 |
| Insertion of stent in ureter using an endoscope | 18 | $1,498 | $68 |
| Ultrasonic guidance for needle placement | 24 | $1,340 | $50 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $1,250 | $27 |
| Insertion of temporary bladder tube | 17 | $1,028 | $45 |
| Electronic assessment of bladder emptying | 39 | $292 | $7 |
2015: 23 services
| Diagnostic exam of bladder and urethra using an endoscope | 134 | $24,431 | $163 |
| Return visit (30+ min) | 217 | $23,895 | $82 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 19 | $22,244 | None |
| New patient visit (45+ min) | 144 | $17,941 | $125 |
| Short return visit (20+ min) | 224 | $15,896 | $57 |
| Insertion of lower leg neurostimulator electrode | 17 | $11,849 | $100 |
| New patient visit (30+ min) | 98 | $7,582 | $77 |
| Ultrasound measurement of bladder capacity after voiding | 324 | $6,756 | $15 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 24 | $6,053 | $252 |
| Long return visit (40+ min) | 34 | $4,006 | $114 |
| Biopsy of prostate gland | 23 | $3,916 | $170 |
| Simple measurement of pressure of urine flow in bladder | 17 | $3,087 | $154 |
| Insertion of device into abdomen with pressure and urine flow rate study | 31 | $2,827 | $91 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 37 | $2,770 | $75 |
| Automated urinalysis test | 466 | $2,427 | $3 |
| Complex measurement of pressure of urine flow in bladder | 11 | $2,383 | $217 |
| Ultrasound scan of pelvic region through rectum | 23 | $1,932 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,633 | $109 |
| Ultrasonic guidance for needle placement | 23 | $1,227 | $49 |
| Simple insertion of temporary bladder tube | 13 | $1,154 | $58 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 19 | $1,096 | $27 |
| Insertion of stent in ureter using an endoscope | 11 | $893 | $74 |
| Electronic assessment of bladder emptying | 24 | $226 | $9 |
2014: 22 services
| New patient visit (45+ min) | 104 | $12,260 | $118 |
| Return visit (30+ min) | 107 | $11,795 | $78 |
| Diagnostic exam of bladder and urethra using an endoscope | 65 | $11,216 | $154 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 37 | $10,032 | $271 |
| Short return visit (20+ min) | 97 | $5,835 | $51 |
| Insertion of device into abdomen with pressure and urine flow rate study | 37 | $3,298 | $89 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 38 | $3,219 | $83 |
| New patient visit (45+ min) | 27 | $2,574 | $95 |
| Ultrasound measurement of bladder capacity after voiding | 116 | $2,092 | $15 |
| Biopsy of prostate gland | 12 | $2,003 | $167 |
| Complete ultrasound scan behind abdominal cavity | 19 | $2,002 | $105 |
| Short return visit (20+ min) | 44 | $1,818 | $33 |
| Manual urinalysis test with examination using microscope, non-automated | 204 | $1,555 | $4 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $1,499 | $100 |
| Return visit (30+ min) | 23 | $1,451 | $48 |
| Simple insertion of temporary bladder tube | 15 | $1,278 | $56 |
| Long return visit (40+ min) | 11 | $1,237 | $112 |
| Complete ultrasound scan of pelvis | 18 | $1,052 | $58 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 42 | $1,041 | $15 |
| Ultrasound scan of pelvic region through rectum | 12 | $917 | $76 |
| Ultrasonic guidance for needle placement | 14 | $840 | $60 |
| Injection, garamycin, gentamicin, up to 80 mg | 14 | $17 | None |
2013: 24 services
| New patient visit (45+ min) | 125 | $15,872 | $127 |
| Short return visit (20+ min) | 131 | $12,965 | $57 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 45 | $12,800 | $284 |
| Diagnostic exam of bladder and urethra using an endoscope | 64 | $11,097 | $166 |
| Return visit (30+ min) | 66 | $7,162 | $85 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 47 | $4,711 | $91 |
| Insertion of device into abdomen with pressure and urine flow rate study | 44 | $4,109 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,189 | $159 |
| Ultrasound measurement of bladder capacity after voiding | 120 | $2,706 | $16 |
| Ultrasonic guidance for needle placement | 12 | $2,122 | $177 |
| Biopsy of prostate gland | 11 | $1,959 | $178 |
| Long return visit (40+ min) | 15 | $1,870 | $117 |
| Short return visit (20+ min) | 40 | $1,868 | $38 |
| Manual urinalysis test with examination using microscope, non-automated | 202 | $1,818 | $4 |
| Complete ultrasound scan behind abdominal cavity | 14 | $1,697 | $113 |
| Simple bladder irrigation and/or instillation | 17 | $1,567 | $68 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $1,345 | $96 |
| New patient visit (30+ min) | 12 | $1,061 | $88 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $1,051 | $17 |
| Complete ultrasound scan of pelvis | 14 | $898 | $60 |
| Return visit (30+ min) | 14 | $858 | $61 |
| New patient visit (30+ min) | 12 | $704 | $59 |
| Ultrasound scan of pelvic region through rectum | 11 | $674 | $61 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $11 | None |
Medicaid work
$1,632 in 2024
Medicaid paid $1,632 for 636 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 110 | $993 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 163 | $256 |
| New patient visit (30+ min) | 38 | $204 |
| Short return visit (20+ min) | 43 | $82 |
| New patient visit (45+ min) | 12 | $79 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 270 | $17 |
| 2024 | 636 | 6 | 29 | $1,632 |
| 2023 | 368 | 6 | 27 | $1,140 |
| 2022 | 312 | 5 | 37 | $1,034 |
| 2021 | 209 | 3 | 21 | $1,028 |
| 2020 | 263 | 2 | 27 | $1,053 |
| 2019 | 321 | 2 | 26 | $1,167 |
| 2018 | 424 | 2 | 31 | $2,296 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 53 | $496 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 15 | $244 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 19 | $237 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 108 | $87 |
| Short return visit (20+ min) | 25 | $66 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 148 | $11 |
2022
| Short return visit (20+ min) | 15 | $571 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 29 | $264 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 27 | $168 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 42 | $32 |
| TOBACCO NON-USER | 199 | $0 |
2021
| Short return visit (20+ min) | 12 | $705 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 184 | $239 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 13 | $84 |
2020
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 67 | $835 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 196 | $219 |
2019
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 70 | $830 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 251 | $337 |
2018
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 136 | $1,820 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 288 | $476 |
Drugs they prescribed that Part D paid
$66,900
Pharmacies billed $66,900 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
272 generic and fewer than 11 brand-name prescriptions · $66,900 in drug cost · 66 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 56 | $59,290 | $1,059 |
| Potassium Citrate Er | 18 | $1,533 | $85 |
| Tamsulosin | 69 | $855 | $12 |
| Oxybutynin Chloride Er | 21 | $482 | $23 |
| Finasteride | 30 | $342 | $11 |
See all 8 drugs
| Myrbetriq | 56 | $59,290 | $1,059 |
| Potassium Citrate Er | 18 | $1,533 | $85 |
| Tamsulosin | 69 | $855 | $12 |
| Oxybutynin Chloride Er | 21 | $482 | $23 |
| Finasteride | 30 | $342 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $148 | $12 |
| Sulfamethoxazole-Trimethoprim | 17 | $54 | $3 |
| Ciprofloxacin | 12 | $51 | $4 |
Year by year
| 2024 | 337 | 143 | None | None | $66,900 |
| 2023 | 236 | 114 | None | None | $30,496 |
| 2022 | 63 | 40 | None | 24% | $13,827 |
| 2021 | 595 | 240 | 2% (14) | None | $75,870 |
| 2020 | 631 | 252 | 4% (27) | None | $74,020 |
| 2019 | 686 | 278 | 2% (13) | None | $75,756 |
| 2018 | 834 | 298 | 5% (40) | None | $89,924 |
| 2017 | 1,168 | 337 | 4% (46) | None | $129,806 |
| 2016 | 1,132 | 298 | 3% (37) | None | $111,062 |
| 2015 | 672 | 208 | 2% (12) | None | $50,940 |
| 2014 | 674 | 178 | 5% (35) | None | $49,983 |
| 2013 | 621 | 166 | 6% (38) | None | $45,722 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Myrbetriq | 32 | $24,452 | $764 |
| Estradiol | 12 | $1,488 | $124 |
| Tamsulosin | 37 | $741 | $20 |
| Amoxicillin-Clavulanate Potass | 21 | $491 | $23 |
| Finasteride | 18 | $350 | $19 |
| Sulfamethoxazole-Trimethoprim | 25 | $183 | $7 |
| Ciprofloxacin | 12 | $134 | $11 |
2022: 1 drug
| Myrbetriq | 14 | $10,932 | $781 |
2021: 13 drugs
| Myrbetriq | 48 | $43,164 | $899 |
| Potassium Citrate Er | 35 | $3,968 | $113 |
| Solifenacin | 31 | $2,927 | $94 |
| Tamsulosin | 75 | $1,473 | $20 |
| Oxybutynin Chloride Er | 32 | $1,459 | $46 |
| Finasteride | 57 | $1,262 | $22 |
| Alfuzosin Hcl Er | 14 | $571 | $41 |
| Amoxicillin-Clavulanate Potass | 25 | $369 | $15 |
| Cephalexin | 38 | $275 | $7 |
| Levofloxacin | 16 | $184 | $12 |
| Tadalafil | 11 | $154 | $14 |
| Ciprofloxacin | 30 | $131 | $4 |
| Sulfamethoxazole-Trimethoprim | 14 | $113 | $8 |
2020: 19 drugs
| Myrbetriq | 54 | $43,709 | $809 |
| Elmiron | 15 | $5,583 | $372 |
| Oxybutynin Chloride Er | 48 | $2,625 | $55 |
| Potassium Citrate Er | 20 | $1,981 | $99 |
| Methenamine Hippurate | 11 | $1,848 | $168 |
| Estradiol | 15 | $1,799 | $120 |
| Tolterodine Tartrate Er | 11 | $1,768 | $161 |
| Solifenacin | 18 | $1,665 | $92 |
| Tamsulosin | 83 | $1,624 | $20 |
| Finasteride | 44 | $1,022 | $23 |
| Alfuzosin Hcl Er | 18 | $672 | $37 |
| Nitrofurantoin Mono-Macro | 17 | $637 | $37 |
| Cephalexin | 43 | $280 | $7 |
| Ciprofloxacin | 36 | $234 | $6 |
| Sulfamethoxazole-Trimethoprim | 33 | $205 | $6 |
| Levofloxacin | 21 | $204 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $170 | $11 |
| Fluconazole | 14 | $160 | $11 |
| Hydrocodone-Acetaminophen | 21 | $51 | $2 |
2019: 18 drugs
| Myrbetriq | 37 | $20,691 | $559 |
| Methenamine Hippurate | 56 | $8,966 | $160 |
| Potassium Citrate Er | 24 | $6,549 | $273 |
| Estradiol | 19 | $3,402 | $179 |
| Oxybutynin Chloride Er | 37 | $2,390 | $65 |
| Tamsulosin | 72 | $2,294 | $32 |
| Solifenacin | 14 | $1,906 | $136 |
| Tolterodine Tartrate Er | 17 | $1,894 | $111 |
| Finasteride | 44 | $1,297 | $29 |
| Nitrofurantoin Mono-Macro | 12 | $1,119 | $93 |
| Alfuzosin Hcl Er | 21 | $591 | $28 |
| Cephalexin | 69 | $493 | $7 |
| Oxybutynin Chloride | 13 | $402 | $31 |
| Levofloxacin | 30 | $388 | $13 |
| Ciprofloxacin | 40 | $261 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $180 | $15 |
| Sulfamethoxazole-Trimethoprim | 29 | $178 | $6 |
| Fluconazole | 13 | $69 | $5 |
2018: 17 drugs
| Botox | 21 | $13,854 | $660 |
| Vesicare | 26 | $12,999 | $500 |
| Methenamine Hippurate | 40 | $5,945 | $149 |
| Tamsulosin | 135 | $4,211 | $31 |
| Tolterodine Tartrate Er | 17 | $3,683 | $217 |
| Potassium Citrate Er | 15 | $3,524 | $235 |
| Estradiol | 16 | $3,009 | $188 |
| Oxybutynin Chloride Er | 40 | $2,822 | $71 |
| Finasteride | 83 | $2,120 | $26 |
| Alfuzosin Hcl Er | 58 | $1,393 | $24 |
| Oxybutynin Chloride | 24 | $932 | $39 |
| Nitrofurantoin Mono-Macro | 12 | $616 | $51 |
| Ciprofloxacin | 60 | $395 | $7 |
| Cephalexin | 65 | $341 | $5 |
| Levofloxacin | 20 | $306 | $15 |
| Sulfamethoxazole-Trimethoprim | 32 | $202 | $6 |
| Hydrocodone-Acetaminophen | 34 | $140 | $4 |
2017: 18 drugs
| Vesicare | 48 | $24,607 | $513 |
| Myrbetriq | 30 | $22,534 | $751 |
| Potassium Citrate Er | 26 | $9,523 | $366 |
| Botox | 13 | $8,917 | $686 |
| Tolterodine Tartrate Er | 35 | $8,624 | $246 |
| Oxybutynin Chloride Er | 123 | $6,841 | $56 |
| Tamsulosin | 195 | $6,249 | $32 |
| Estrace | 21 | $6,065 | $289 |
| Methenamine Hippurate | 25 | $4,967 | $199 |
| Rapaflo | 11 | $3,400 | $309 |
| Finasteride | 136 | $3,173 | $23 |
| Oxybutynin Chloride | 35 | $1,944 | $56 |
| Alfuzosin Hcl Er | 78 | $1,941 | $25 |
| Cephalexin | 79 | $483 | $6 |
| Ciprofloxacin | 53 | $412 | $8 |
| Sulfamethoxazole-Trimethoprim | 38 | $293 | $8 |
| Hydrocodone-Acetaminophen | 45 | $243 | $5 |
| Levofloxacin | 14 | $155 | $11 |
2016: 18 drugs
| Vesicare | 40 | $21,362 | $534 |
| Myrbetriq | 18 | $8,845 | $491 |
| Estrace | 29 | $7,676 | $265 |
| Oxybutynin Chloride Er | 168 | $7,356 | $44 |
| Tamsulosin | 182 | $6,778 | $37 |
| Tolterodine Tartrate Er | 21 | $5,547 | $264 |
| Potassium Citrate Er | 23 | $5,226 | $227 |
| Rapaflo | 12 | $4,767 | $397 |
| Methenamine Hippurate | 23 | $3,414 | $148 |
| Finasteride | 129 | $2,896 | $22 |
| Nitrofurantoin Mono-Macro | 31 | $1,781 | $57 |
| Alfuzosin Hcl Er | 77 | $1,590 | $21 |
| Oxybutynin Chloride | 33 | $1,439 | $44 |
| Trospium Chloride | 12 | $1,202 | $100 |
| Ciprofloxacin | 82 | $634 | $8 |
| Cephalexin | 59 | $430 | $7 |
| Hydrocodone-Acetaminophen | 36 | $360 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $170 | $9 |
2015: 17 drugs
| Vesicare | 21 | $12,348 | $588 |
| Tamsulosin | 143 | $5,179 | $36 |
| Rapaflo | 12 | $4,189 | $349 |
| Oxybutynin Chloride Er | 57 | $2,924 | $51 |
| Tolterodine Tartrate Er | 12 | $2,655 | $221 |
| Potassium Citrate Er | 15 | $2,104 | $140 |
| Tolterodine | 15 | $1,999 | $133 |
| Trospium Chloride | 16 | $1,714 | $107 |
| Finasteride | 84 | $1,280 | $15 |
| Nitrofurantoin Mono-Macro | 17 | $942 | $55 |
| Oxybutynin Chloride | 24 | $806 | $34 |
| Nitrofurantoin | 14 | $513 | $37 |
| Alfuzosin Hcl Er | 28 | $486 | $17 |
| Ciprofloxacin | 60 | $358 | $6 |
| Cephalexin | 41 | $328 | $8 |
| Hydrocodone-Acetaminophen | 11 | $174 | $16 |
| Allopurinol | 11 | $167 | $15 |
2014: 16 drugs
| Vesicare | 28 | $9,933 | $355 |
| Oxybutynin Chloride Er | 98 | $6,723 | $69 |
| Premarin | 20 | $4,248 | $212 |
| Tamsulosin | 162 | $4,141 | $26 |
| Estrace | 22 | $3,591 | $163 |
| Tolterodine | 16 | $3,051 | $191 |
| Toviaz | 11 | $2,834 | $258 |
| Oxybutynin Chloride | 29 | $1,389 | $48 |
| Nitrofurantoin Mono-Macro | 21 | $1,291 | $61 |
| Finasteride | 37 | $729 | $20 |
| Cephalexin | 32 | $347 | $11 |
| Alfuzosin Hcl Er | 15 | $337 | $22 |
| Ciprofloxacin | 44 | $298 | $7 |
| Hydrocodone-Acetaminophen | 33 | $261 | $8 |
| Terazosin | 12 | $95 | $8 |
| Sulfamethoxazole-Trimethoprim | 11 | $51 | $5 |
2013: 14 drugs
| Vesicare | 43 | $13,621 | $317 |
| Premarin | 42 | $7,816 | $186 |
| Oxybutynin Chloride Er | 114 | $7,451 | $65 |
| Tamsulosin | 118 | $2,667 | $23 |
| Toviaz | 11 | $2,131 | $194 |
| Trospium Chloride | 14 | $1,905 | $136 |
| Nitrofurantoin Mono-Macro | 18 | $1,159 | $64 |
| Finasteride | 24 | $848 | $35 |
| Desmopressin Acetate | 13 | $575 | $44 |
| Hydrocodone-Acetaminophen | 38 | $384 | $10 |
| Polyethylene Glycol 3350 | 12 | $281 | $23 |
| Ciprofloxacin | 32 | $265 | $8 |
| Cephalexin | 29 | $262 | $9 |
| Sulfamethoxazole-Trimethoprim | 18 | $142 | $8 |
Money from drug and device companies
$304 in 2025
| 2025 | 4 | 10 | None | $304 |
| 2024 | 7 | 28 | None | $2,878 |
| 2023 | 7 | 8 | None | $481 |
| 2022 | 4 | 5 | None | $123 |
| 2021 | 5 | 7 | None | $217 |
| 2020 | 2 | 5 | None | $95 |
| 2019 | 3 | 7 | None | $201 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Erectile Dysfunction | $145 | 7 payments
|
| Calyxo | Cvac Aspiration System | $131 | 1 payment
|
| Procept Biorobotics | Aquabeam Robotic System | $26 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $3 | 1 payment
|
See all 10 published payments
| Boston Scientific | Meals · 2025-12-22 | Ams 800 Artificial Urinary Sphincter | $23 |
| Calyxo | Meals · 2025-11-19 | Cvac Aspiration System | $131 |
| Boston Scientific | Meals · 2025-10-25 | General - Erectile Dysfunction | $16 |
| Procept Biorobotics | Meals · 2025-09-19 | Aquabeam Robotic System | $26 |
| Boston Scientific | Meals · 2025-09-04 | General - Erectile Dysfunction | $3 |
| Boston Scientific | Meals · 2025-08-29 | General - Erectile Dysfunction | $16 |
| Boston Scientific | Meals · 2025-06-03 | General - Erectile Dysfunction | $28 |
| Intuitive Surgical | Meals · 2025-03-25 | Da Vinci Surgical System | $3 |
| Boston Scientific | Meals · 2025-02-06 | General - Erectile Dysfunction | $23 |
| Boston Scientific | Meals · 2025-02-06 | General - Erectile Dysfunction | $34 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,878
| Intuitive Surgical | Davinci Xi | $2,640 | 11 payments
|
| Boston Scientific | Ams 700 | $133 | 12 payments
|
| Urogen Pharma | Jelmyto | $29 | 1 payment
|
| Immunitybio | Anktiva | $22 | 1 payment
|
| KARL STORZ Endoscopy-America | Hopkins | $20 | 1 payment
|
| Abbvie | Botox | $18 | 1 payment
|
| Dentsply Ih Ab | Lofric | $17 | 1 payment
|
2023: $481
| Dornier MedTech America | Dornier Medtech | $257 | 1 payment
|
| Laborie Medical Technologies | None | $81 | 2 payments
|
| Teleflex | Urolift | $42 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $38 | 1 payment
|
| AbbVie | Botox | $23 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $21 | 1 payment
|
| Boston Scientific | Lithovue | $19 | 1 payment
|
2022: $123
| Boston Scientific | General - Erectile Dysfunction | $49 | 2 payments
|
| Axonics | Axonics | $35 | 1 payment
|
| Teleflex | Urolift System | $25 | 1 payment
|
| Coloplast | Speedicath | $14 | 1 payment
|
2021: $217
| Boston Scientific | Spaceoar Vue | $105 | 2 payments
|
| Astellas Pharma US | None | $52 | 1 payment
|
| Axonics | Axonics R-Snm System | $26 | 2 payments
|
| Coloplast | Altis | $17 | 1 payment
|
| 180 Medical | Gentlecath | $17 | 1 payment
|
2020: $95
| Boston Scientific | Spaceoar | $62 | 3 payments
|
| Coloplast | Speedicath | $33 | 2 payments
|
2019: $201
| Allergan | Botox | $103 | 5 payments
|
| NeoTract | Urolift | $86 | 1 payment
|
| Boston Scientific | General Therapies | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154681906
- Licence
- CA A120129California A120129: Current · expires 2028-01-31
- Trained
- Pennsylvania State University College of Medicine, 2007 · 19 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 23845 Holman Hwy Ste 203, Monterey, CA, 93940
- NPI first listed
- 2012-05-25
- NPI last updated
- 2018-05-11
This is when the NPI record was last certified, not a medical board exam.